Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and brochodilators for severe and very severe COPD patients
RD Negro, M Eandi, L Pradelli… - International Journal of …, 2007 - Taylor & Francis
Current practice guidelines for the treatment of COPD recommend the use of combined
inhaled corticosteroids and long-acting bronchodilators in severe and very severe patients …
inhaled corticosteroids and long-acting bronchodilators in severe and very severe patients …
The effect on total mortality of adding inhaled corticosteroids to long-acting bronchodilators for COPD: a real practice analysis in Italy
M Di Martino, N Agabiti, S Cascini… - COPD: Journal of …, 2016 - Taylor & Francis
Purpose. Chronic therapy with long-acting bronchodilators (LB) is recommended to treat
moderate-to-severe COPD. Although the benefits of adding inhaled corticosteroid (ICS) to …
moderate-to-severe COPD. Although the benefits of adding inhaled corticosteroid (ICS) to …
Outcomes and costs of treating chronic obstructive pulmonary disease with inhaled fixed combinations: the Italian perspective of the PATHOS study
A Roggeri, C Micheletto, DP Roggeri - International Journal of …, 2014 - Taylor & Francis
Purpose Fixed-dose combinations of inhaled corticosteroids and long-acting β2-agonists
have proven to prevent and reduce chronic obstructive pulmonary disease (COPD) …
have proven to prevent and reduce chronic obstructive pulmonary disease (COPD) …
[HTML][HTML] Economic impact of reducing inappropriate inhaled corticosteroids use in patients with chronic obstructive pulmonary disease: ISPOR's guidance on budget …
Objectives To assess the budget impact of restricting inappropriate inhaled corticosteroids
(ICS) use according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) …
(ICS) use according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) …
Overtreatment of COPD with inhaled corticosteroids-implications for safety and costs: cross-sectional observational study
Introduction Combined inhaled long-acting beta-agonists and corticosteroids (LABA+ ICS)
are costly. They are recommended in severe or very severe chronic obstructive pulmonary …
are costly. They are recommended in severe or very severe chronic obstructive pulmonary …
Methodological issues in therapeutic trials of COPD
The recent Towards a Revolution in COPD Health (TORCH) randomised trial replicated the
findings of previous trials in chronic obstructive pulmonary disease (COPD) on the apparent …
findings of previous trials in chronic obstructive pulmonary disease (COPD) on the apparent …
Inhaled corticosteroid use among COPD patients in primary care in Spain
M Miravitlles, M Roman-Rodríguez… - … journal of chronic …, 2022 - Taylor & Francis
Purpose Inhaled corticosteroids (ICS) are frequently used to treat chronic obstructive
pulmonary disease (COPD) outside the current recommendations. Our aim was to describe …
pulmonary disease (COPD) outside the current recommendations. Our aim was to describe …
The dose of inhaled corticosteroids in patients with COPD: when less is better
JL Izquierdo, BG Cosio - International Journal of Chronic …, 2018 - Taylor & Francis
Background The use of inhaled corticosteroids (ICS) in combination with bronchodilators in
patients with COPD has been shown to decrease the rate of disease exacerbations and to …
patients with COPD has been shown to decrease the rate of disease exacerbations and to …
Cost-effectiveness analysis of three different combinations of inhalers for severe and very severe chronic obstructive pulmonary disease patients at a tertiary care …
M Altaf, AM Zubedi, F Nazneen… - … in Clinical Research, 2015 - journals.lww.com
Background: This study aims at simplifying the practical patient management and offers
some general indications for pharmacotherapeutic choice by the implementation of (Global …
some general indications for pharmacotherapeutic choice by the implementation of (Global …
Recommendations for COPD management in Central and Eastern Europe
A Valipour, Z Aisanov, S Avdeev… - Expert Review of …, 2022 - Taylor & Francis
ABSTRACT Introduction The Global Initiative for Chronic Obstructive Lung Disease (GOLD)
strategy report provides guidance on effective management of chronic obstructive …
strategy report provides guidance on effective management of chronic obstructive …